← Leaderboards
Rolando Herrero
Fundacion Inciensa
$14,003,389
Attributed
$14,003,389
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8M · FY2009–12$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
Funding mix
By agency
NIH$14,003,389 · 1
By mechanism
N01$14,003,389 · 1
Top collaborators
No co-investigators on record.
Most similar at Fundacion Inciensa
Same institution · by research overlap
- Paula Gonzalez-Maya$38,145,031
- Carolina Porras$11,742,990
- Paula Gonzalez$28,686,384
- Charles Sanchez$787,124
- Ana Cecilia Rodriguez$4,601,397
Others in their field
Top investigators on “Human Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,091,618
Research focus
Human PapillomavirusHuman Papilloma Virus VaccineScreening ProcedureVirus-Like ParticleCosta RicaProgramsNatural HistorySafetyVaccinationVaccinesCytologyVaccinatedEffectivenessResponseBaseEfficacy EvaluationClinical Trials Data Monitoring CommitteesDrug FormulationsDoseCervix UteriAnusHpv-16/18 VaccineHuman Papillomavirus 16High Risk
Grant awards (4)
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$870,317
N01 · FY2012 · CA · contact PI
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,236,717
N01 · FY2011 · CA · contact PI
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,794,576
N01 · FY2010 · CA · contact PI
HPV TYPE 16 VACCINE TRIAL IN COSTA RICA$4,101,779
N01 · FY2009 · CA · contact PI